Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever

Lancet (London, England)
|February 9, 2000
PubMed

Insights

Familial Mediterranean fever (FMF) is an inflammatory condition. Studies show FMF patients, particularly those of non-Ashkenazi Jewish descent, have a higher frequency and severity of inflammatory bowel disease (IBD).

Area of Science:

  • Genetics and Immunology
  • Gastroenterology

Background:

  • Familial Mediterranean fever (FMF) and inflammatory bowel disease (IBD) are distinct autoinflammatory and chronic inflammatory conditions, respectively.
  • Previous research suggests a potential link between FMF and IBD, but specific patient populations and disease severity require further investigation.

Discussion:

  • This study highlights a significant association between FMF and IBD, particularly in non-Ashkenazi Jewish individuals.
  • The findings suggest that FMF may exacerbate the frequency and severity of IBD in this specific demographic.
  • Understanding this comorbidity is crucial for accurate diagnosis and effective management strategies.

Key Insights:

  • Inflammatory bowel disease (IBD) occurs with notable frequency and increased severity in patients diagnosed with familial Mediterranean fever (FMF).
  • The association is particularly pronounced in individuals of non-Ashkenazi Jewish heritage.
  • This suggests a potential shared genetic or inflammatory pathway influencing both conditions in this population.

Outlook:

  • Further research is warranted to elucidate the underlying mechanisms connecting FMF and IBD in non-Ashkenazi Jewish populations.
  • Investigating targeted therapies for IBD in FMF patients could improve clinical outcomes.
  • Longitudinal studies are needed to track disease progression and response to treatment.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...